ABSTRACT
Chemokines play well established roles as attractants of naïve and effector T cells. New studies indicate that chemokines also have roles in regulating T cell differentiation. Blocking Gi protein-coupled receptor signaling by pertussis toxin as well as deficiencies in G alpha 12, chemokine receptor 2 (CCR2), CCR5, chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein 1, or MCP-1), CCL3 (macrophage inflammatory protein 1 alpha, or MIP-1 alpha) and CCL5 (RANTES) have all been found to have effects on the magnitude and cytokine polarity of the T cell response. Here we focus on findings in the CCL2-CCR2 and CCL3-CCR5 ligand-receptor systems. The roles of these molecules in regulating T cell fate include possible indirect effects on antigen-presenting cells and direct effects on differentiating T cells. Models to account for the action of chemokines and G protein-coupled receptor signals in regulating T cell differentiation are discussed.
Subject(s)
Chemokines/immunology , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Animals , Cell Differentiation/immunology , GTP-Binding Protein alpha Subunits, Gi-Go/metabolism , Humans , Interleukin-12/biosynthesis , Ligands , Models, Biological , Receptors, CCR1 , Receptors, CCR2 , Receptors, CCR5/immunology , Receptors, CCR5/metabolism , Receptors, Chemokine/immunology , Receptors, Chemokine/metabolism , Signal Transduction , T-Lymphocytes/metabolismABSTRACT
The spontaneous mutant mouse strain, plt/plt, lacks the secondary lymphoid organ chemokine (SLC)-ser gene and has disrupted trafficking of T cells and dendritic cells (DCs) to lymphoid tissues. We demonstrate here that the gene for the related chemokine, Epstein-Barr virus-induced molecule-1 ligand chemokine (ELC), is also deleted in this immunodeficient mouse strain. Using a combination of approaches, including bone marrow reconstitution and double in situ hybridization, we show in wild-type mice that ELC is expressed by T zone stromal cells that also make SLC. Smaller amounts of ELC are made by DCs, predominantly of the CD8(+) phenotype. We propose that ELC- and SLC-expressing T zone stromal cells play a central role in bringing naive T cells and DCs together for the initiation of immune responses.
Subject(s)
Chemokines, CC/genetics , Animals , Base Sequence , Chemokine CCL19 , Chemokine CCL21 , Codon, Initiator , DNA, Complementary , Dendritic Cells/metabolism , Gene Expression , Lymphoid Tissue/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Mutant Strains , Molecular Sequence Data , Stromal Cells/metabolism , Tissue DistributionABSTRACT
Follicular dendritic cells (FDCs), the best defined stromal cell subset within lymphoid follicles, play a critical role in presenting intact antigen to B lymphocytes. The discovery that many follicular stromal cells make B-lymphocyte chemoattractant (BLC), a CXC chemokine that attracts CXCR5+ cells, provides a basis for understanding how motile B cells come into contact with stationary FDCs. Here we review our work on BLC and discuss properties of BLC-expressing follicular stromal cells. We also review the properties of primary follicle and germinal center FDCs and suggest a model of FDC development that incorporates information about BLC expression. Finally, we consider how antigen recognition causes T and B lymphocytes to undergo changes in chemokine responsiveness that may help direct their movements into, or out of, lymphoid follicles.
Subject(s)
Dendritic Cells, Follicular/cytology , Dendritic Cells, Follicular/immunology , Lymphocytes/cytology , Lymphocytes/immunology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Cell Movement , Chemokine CXCL13 , Chemokines, CXC/metabolism , Humans , Lymphoid Tissue/cytology , Lymphoid Tissue/immunology , Lymphotoxin-alpha/metabolism , Mice , Models, Biological , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Lymphoid follicles are B-cell-rich compartments of lymphoid organs that function as sites of B-cell antigen encounter and differentiation. CXC chemokine receptor-5 (CXCR5) is required for B-cell migration to splenic follicles, but the requirements for homing to B-cell areas in lymph nodes remain to be defined. Here we show that lymph nodes contain two types of B-cell-rich compartment: follicles containing follicular dendritic cells, and areas lacking such cells. Using gene-targeted mice, we establish that B-lymphocyte chemoattractant (BLC/BCA1) and its receptor, CXCR5, are needed for B-cell homing to follicles in lymph nodes as well as in spleen. We also find that BLC is required for the development of most lymph nodes and Peyer's patches. In addition to mediating chemoattraction, BLC induces B cells to up-regulate membrane lymphotoxin alpha1beta2, a cytokine that promotes follicular dendritic cell development and BLC expression, establishing a positive feedback loop that is likely to be important in follicle development and homeostasis. In germinal centres the feedback loop is overridden, with B-cell lymphotoxin alpha1beta2 expression being induced by a mechanism independent of BLC.
Subject(s)
B-Lymphocytes/physiology , Chemokines, CXC/physiology , Lymph Nodes/physiology , Receptors, Cytokine/physiology , Animals , B-Lymphocytes/cytology , Cell Differentiation , Cells, Cultured , Chemokine CXCL13 , Chemokines, CXC/genetics , Dendritic Cells/physiology , Feedback , Female , Lymph Nodes/anatomy & histology , Lymph Nodes/cytology , Lymph Nodes/growth & development , Lymphotoxin-alpha/biosynthesis , Male , Mice , Peyer's Patches/growth & development , Receptors, CXCR5 , Receptors, Chemokine , Receptors, Cytokine/geneticsABSTRACT
CXCR5, the receptor for B lymphocyte chemoattractant (BLC), is required for normal development of Peyer's patches, inguinal lymph nodes, and splenic follicles. To test the in vivo activity of BLC in isolation of other lymphoid organizers, transgenic mice were generated expressing BLC in the pancreatic islets. In addition to attracting B cells, BLC expression led to development of lymph node-like structures that contained B and T cell zones, high endothelial venules, stromal cells, and the chemokine SLC. Development of these features was strongly dependent on B lymphocytes and on lymphotoxin alpha1beta2 and could be reversed by blocking lymphotoxin alpha1beta2. These findings establish that BLC is sufficient to activate a pathway of events leading to formation of organized lymphoid tissue.
Subject(s)
B-Lymphocytes/immunology , Islets of Langerhans/immunology , Lymphotoxin-alpha/immunology , Receptors, Cytokine/immunology , Animals , B-Lymphocytes/pathology , Chemotactic Factors/immunology , Islets of Langerhans/pathology , Lymphoid Tissue/immunology , Lymphoid Tissue/pathology , Mice , Mice, Transgenic , Receptors, CXCR5 , Receptors, ChemokineABSTRACT
Mouse mammary tumor virus has developed strategies to exploit the immune response. It requires vigorous immune stimulation to achieve efficient infection. The infected antigen-presenting cells present a viral superantigen on the cell surface which stimulates strong CD4-mediated T-cell help but CD8 T-cell responses are undetectable. Despite the high frequency of superantigen-reactive T cells, the superantigen-induced immune response is comparable to classical antigen responses in terms of T-cell priming, T-cell-B-cell collaboration as well as follicular and extra-follicular B-cell differentiation. Induction of systemic anergy is observed, similar to classical antigen responses where antigen is administered systemically but does not influence the role of the superantigen-reactive T cells in the maintenance of the chronic germinal center reaction. So far we have been unable to detect a cytotoxic T-cell response to mouse mammary tumor virus peptide antigens or to the superantigen. This might yet represent another step in the viral infection strategy.
Subject(s)
Antibody Formation , Immunity, Cellular , Mammary Tumor Virus, Mouse/immunology , Retroviridae Infections/immunology , Tumor Virus Infections/immunology , Amino Acid Sequence , Animals , Antigen-Presenting Cells/immunology , Antigens, Viral/immunology , Humans , Mice , Molecular Sequence Data , Superantigens/immunology , T-Lymphocytes/immunology , T-Lymphocytes, Cytotoxic/immunology , Virus Diseases/immunologyABSTRACT
The respective production of specific immunoglobulin (Ig)G2a or IgG1 within 5 d of primary immunization with Swiss type mouse mammary tumor virus [MMTV(SW)] or haptenated protein provides a model for the development of T helper 1 (Th1) and Th2 responses. The antibody-producing cells arise from cognate T cell B cell interaction, revealed by the respective induction of Cgamma2a and Cgamma1 switch transcript production, on the third day after immunization. T cell proliferation and upregulation of mRNA for interferon gamma in response to MMTV(SW) and interleukin 4 in response to haptenated protein also starts during this day. It follows that there is minimal delay in these responses between T cell priming and the onset of cognate interaction between T and B cells leading to class switching and exponential growth. The Th1 or Th2 profile is at least partially established at the time of the first cognate T cell interaction with B cells in the T zone. The addition of killed Bordetella pertussis to the hapten-protein induces nonhapten-specific IgG2a and IgG1 plasma cells, whereas the anti-hapten response continues to be IgG1 dominated. This indicates that a Th2 response to hapten-protein can proceed in a node where there is substantial Th1 activity.
Subject(s)
Immunoglobulin Class Switching , Lymphocyte Activation , Th1 Cells , Th2 Cells , Vaccination , Animals , Bordetella pertussis/immunology , Germinal Center/immunology , Haptens/immunology , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , Lymph Nodes/cytology , Lymph Nodes/immunology , Mammary Tumor Virus, Mouse/immunology , Mice , Mice, Inbred BALB C , Plasma Cells , Spleen/cytology , Spleen/immunology , gamma-Globulins/immunologyABSTRACT
Infectious mouse mammary tumor virus (MMTV) is a retrovirus that expresses a superantigen shortly after infection of B cells. The superantigen first drives the polyclonal activation and proliferation of superantigen-reactive CD4+ T cells, which then induce the infected B cells to proliferate and differentiate. Part of the MMTV-induced B cell response leads to the production of Abs that are specific for the viral envelope protein gp52. Here we show that this Ab response has virus-neutralizing activity and confers protection against superinfection by other MMTV strains in vivo as soon as 4 to 7 days after infection. A protective Ab titer is maintained lifelong. Viral infection as well as the superantigen-induced T-B collaboration are required to generate this rapid and long lasting neutralizing Ab response. Polyclonal or superantigen-independent B cell activation, on the contrary, does not lead to detectable virus neutralization. The early onset of this superantigen-dependent neutralizing response suggests that viral envelope-specific B cells are selectively recruited to form part of the extrafollicular B cell response and are subsequently amplified and maintained by superantigen-reactive Th cells.
Subject(s)
Antibodies, Viral/immunology , B-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/immunology , Mammary Tumor Virus, Mouse/immunology , Retroviridae Infections/immunology , Superantigens/immunology , Tumor Virus Infections/immunology , Animals , CD4-Positive T-Lymphocytes/virology , Immunity , Lymphocyte Activation/immunology , Mice , Mice, Inbred BALB CABSTRACT
Recirculating virgin CD4+ T cells spend their life migrating between the T zones of secondary lymphoid tissues where they screen the surface of interdigitating dendritic cells. T-cell priming starts when processed peptides or superantigen associated with class II MHC molecules are recognised. Those primed T cells that remain within the lymphoid tissue move to the outer T zone, where they interact with B cells that have taken up and processed antigen. Cognate interaction between these cells initiates immunoglobulin (Ig) class switch-recombination and proliferation of both B and T cells; much of this growth occurs outside the T zones B cells migrate to follicles, where they form germinal centres, and to extrafollicular sites of B-cell growth, where they differentiate into mainly short-lived plasma cells. T cells do not move to the extrafollicular foci, but to the follicles; there they proliferate and are subsequently involved in the selection of B cells that have mutated their Ig variable-region genes. During primary antibody responses T-cell proliferation in follicles produces many times the peak number of T cells found in that site: a substantial proportion of the CD4+ memory T-cell pool may originate from growth in follicles.
Subject(s)
Antibody Formation/immunology , B-Lymphocytes/immunology , T-Lymphocytes/immunology , Animals , B-Lymphocytes/cytology , Cell Movement , Dendritic Cells/immunology , Humans , Lymphocyte Activation , Receptors, Antigen, B-Cell/immunology , T-Lymphocytes/cytologySubject(s)
B-Lymphocytes/immunology , Retroviridae Infections/immunology , Tumor Virus Infections/immunology , Animals , B-Lymphocytes/pathology , Lymph Nodes/pathology , Mammary Tumor Virus, Mouse , Mice , Mice, Inbred BALB C , Retroviridae Infections/pathology , Superantigens/immunology , Tumor Virus Infections/pathologyABSTRACT
Mouse mammary tumor virus (MMTV[SW]) encodes a superantigen expressed by infected B cells. It evokes an antibody response specific for viral envelope protein, indicating selective activation of antigen-specific B cells. The response to MMTV(SW) in draining lymph nodes was compared with the response to haptenated chicken gamma globulin (NP-CGG) using flow cytometry and immunohistology. T cell priming occurs in both responses, with T cells proliferating in association with interdigitating dendritic cells in the T zone. T cell proliferation continues in the presence of B cells in the outer T zone, and B blasts then undergo exponential growth and differentiation into plasma cells in the medullary cords. Germinal centers develop in both responses, but those induced by MMTV(SW) appear later and are smaller. Most T cells activated in the T zone and germinal centers in the MMTV(SW) response are superantigen specific and these persist for weeks in lymph nodes draining the site MMTV(SW) injection: this contrasts with the selective loss of superantigen-specific T cells from other secondary lymphoid tissues. The results indicate that this viral superantigen, when expressed by professional antigen-presenting cells, drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production.
Subject(s)
Antibodies, Viral/biosynthesis , B-Lymphocytes/physiology , Mammary Tumor Virus, Mouse/immunology , Superantigens/physiology , Animals , Cell Differentiation , Chickens , Lymphocyte Activation , Mice , Mice, Inbred BALB C , Rats , T-Lymphocytes/physiology , gamma-Globulins/immunologyABSTRACT
Superantigens of mouse mammary tumor virus induce a strong cognate interaction between T cells and B cells. In addition to amplifying the virus-infected B-cell pool, this superantigen-driven interaction leads to the differentiation of virus-specific B cells into plasma cells. Successful interaction between T cells and B cells is required for completion of the viral life cycle.